Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 279 entries
Sorted by: Best Match Show Resources per page
Nuclear structure towards N = 40 60Ca: in-beam γ-ray spectroscopy of 58,60Ti.

Physical review letters

Gade A, Janssens RV, Weisshaar D, Brown BA, Lunderberg E, Albers M, Bader VM, Baugher T, Bazin D, Berryman JS, Campbell CM, Carpenter MP, Chiara CJ, Crawford HL, Cromaz M, Garg U, Hoffman CR, Kondev FG, Langer C, Lauritsen T, Lee IY, Lenzi SM, Matta JT, Nowacki F, Recchia F, Sieja K, Stroberg SR, Tostevin JA, Williams SJ, Wimmer K, Zhu S.
PMID: 24702356
Phys Rev Lett. 2014 Mar 21;112(11):112503. doi: 10.1103/PhysRevLett.112.112503. Epub 2014 Mar 21.

Excited states in the neutron-rich N = 38, 36 nuclei (60)Ti and (58)Ti were populated in nucleon-removal reactions from (61)V projectiles at 90 MeV/nucleon. The γ-ray transitions from such states in these Ti isotopes were detected with the advanced...

Cite
Gade A, Janssens RV, Weisshaar D, et al. Nuclear structure towards N = 40 60Ca: in-beam γ-ray spectroscopy of 58,60Ti. Phys Rev Lett. 2014;112(11):112503doi: 10.1103/PhysRevLett.112.112503.
Gade, A., Janssens, R. V., Weisshaar, D., Brown, B. A., Lunderberg, E., Albers, M., Bader, V. M., Baugher, T., Bazin, D., Berryman, J. S., Campbell, C. M., Carpenter, M. P., Chiara, C. J., Crawford, H. L., Cromaz, M., Garg, U., Hoffman, C. R., Kondev, F. G., Langer, C., Lauritsen, T., Lee, I. Y., Lenzi, S. M., Matta, J. T., Nowacki, F., Recchia, F., Sieja, K., Stroberg, S. R., Tostevin, J. A., Williams, S. J., Wimmer, K., & Zhu, S. (2014). Nuclear structure towards N = 40 60Ca: in-beam γ-ray spectroscopy of 58,60Ti. Physical review letters, 112(11), 112503. https://doi.org/10.1103/PhysRevLett.112.112503
Gade, A, et al. "Nuclear structure towards N = 40 60Ca: in-beam γ-ray spectroscopy of 58,60Ti." Physical review letters vol. 112,11 (2014): 112503. doi: https://doi.org/10.1103/PhysRevLett.112.112503
Gade A, Janssens RV, Weisshaar D, Brown BA, Lunderberg E, Albers M, Bader VM, Baugher T, Bazin D, Berryman JS, Campbell CM, Carpenter MP, Chiara CJ, Crawford HL, Cromaz M, Garg U, Hoffman CR, Kondev FG, Langer C, Lauritsen T, Lee IY, Lenzi SM, Matta JT, Nowacki F, Recchia F, Sieja K, Stroberg SR, Tostevin JA, Williams SJ, Wimmer K, Zhu S. Nuclear structure towards N = 40 60Ca: in-beam γ-ray spectroscopy of 58,60Ti. Phys Rev Lett. 2014 Mar 21;112(11):112503. doi: 10.1103/PhysRevLett.112.112503. Epub 2014 Mar 21. PMID: 24702356.
Copy Download .nbib Format: NLM
A desensitization protocol for delayed allergy to cytarabine: analysis of two cases.

Postepy dermatologii i alergologii

Albanesi M, Carluccio P, Nico A, Giliberti L, Di Bona D, Caiaffa MF, Specchia G, Macchia L.
PMID: 29760627
Postepy Dermatol Alergol. 2018 Apr;35(2):222-224. doi: 10.5114/ada.2018.75249. Epub 2018 Apr 24.

No abstract available.

Cite
Albanesi M, Carluccio P, Nico A, et al. A desensitization protocol for delayed allergy to cytarabine: analysis of two cases. Postepy Dermatol Alergol. 2018;35(2):222-224doi: 10.5114/ada.2018.75249.
Albanesi, M., Carluccio, P., Nico, A., Giliberti, L., Di Bona, D., Caiaffa, M. F., Specchia, G., & Macchia, L. (2018). A desensitization protocol for delayed allergy to cytarabine: analysis of two cases. Postepy dermatologii i alergologii, 35(2), 222-224. https://doi.org/10.5114/ada.2018.75249
Albanesi, Marcello, et al. "A desensitization protocol for delayed allergy to cytarabine: analysis of two cases." Postepy dermatologii i alergologii vol. 35,2 (2018): 222-224. doi: https://doi.org/10.5114/ada.2018.75249
Albanesi M, Carluccio P, Nico A, Giliberti L, Di Bona D, Caiaffa MF, Specchia G, Macchia L. A desensitization protocol for delayed allergy to cytarabine: analysis of two cases. Postepy Dermatol Alergol. 2018 Apr;35(2):222-224. doi: 10.5114/ada.2018.75249. Epub 2018 Apr 24. PMID: 29760627; PMCID: PMC5949556.
Copy Download .nbib Format: NLM
Evidence for Coexisting Shapes through Lifetime Measurements in ^{98}Zr.

Physical review letters

Singh P, Korten W, Hagen TW, Görgen A, Grente L, Salsac MD, Farget F, Clément E, de France G, Braunroth T, Bruyneel B, Celikovic I, Delaune O, Dewald A, Dijon A, Delaroche JP, Girod M, Hackstein M, Jacquot B, Libert J, Litzinger J, Ljungvall J, Louchart C, Gottardo A, Michelagnoli C, Müller-Gatermann C, Napoli DR, Otsuka T, Pillet N, Recchia F, Rother W, Sahin E, Siem S, Sulignano B, Togashi T, Tsunoda Y, Theisen C, Valiente-Dobon JJ.
PMID: 30468600
Phys Rev Lett. 2018 Nov 09;121(19):192501. doi: 10.1103/PhysRevLett.121.192501.

The lifetimes of the first excited 2^{+}, 4^{+}, and 6^{+} states in ^{98}Zr were measured with the recoil-distance Doppler shift method in an experiment performed at GANIL. Excited states in ^{98}Zr were populated using the fission reaction between a...

Cite
Singh P, Korten W, Hagen TW, et al. Evidence for Coexisting Shapes through Lifetime Measurements in ^{98}Zr. Phys Rev Lett. 2018;121(19):192501doi: 10.1103/PhysRevLett.121.192501.
Singh, P., Korten, W., Hagen, T. W., Görgen, A., Grente, L., Salsac, M. D., Farget, F., Clément, E., de France, G., Braunroth, T., Bruyneel, B., Celikovic, I., Delaune, O., Dewald, A., Dijon, A., Delaroche, J. P., Girod, M., Hackstein, M., Jacquot, B., Libert, J., Litzinger, J., Ljungvall, J., Louchart, C., Gottardo, A., Michelagnoli, C., Müller-Gatermann, C., Napoli, D. R., Otsuka, T., Pillet, N., Recchia, F., Rother, W., Sahin, E., Siem, S., Sulignano, B., Togashi, T., Tsunoda, Y., Theisen, C., & Valiente-Dobon, J. J. (2018). Evidence for Coexisting Shapes through Lifetime Measurements in ^{98}Zr. Physical review letters, 121(19), 192501. https://doi.org/10.1103/PhysRevLett.121.192501
Singh, Purnima, et al. "Evidence for Coexisting Shapes through Lifetime Measurements in ^{98}Zr." Physical review letters vol. 121,19 (2018): 192501. doi: https://doi.org/10.1103/PhysRevLett.121.192501
Singh P, Korten W, Hagen TW, Görgen A, Grente L, Salsac MD, Farget F, Clément E, de France G, Braunroth T, Bruyneel B, Celikovic I, Delaune O, Dewald A, Dijon A, Delaroche JP, Girod M, Hackstein M, Jacquot B, Libert J, Litzinger J, Ljungvall J, Louchart C, Gottardo A, Michelagnoli C, Müller-Gatermann C, Napoli DR, Otsuka T, Pillet N, Recchia F, Rother W, Sahin E, Siem S, Sulignano B, Togashi T, Tsunoda Y, Theisen C, Valiente-Dobon JJ. Evidence for Coexisting Shapes through Lifetime Measurements in ^{98}Zr. Phys Rev Lett. 2018 Nov 09;121(19):192501. doi: 10.1103/PhysRevLett.121.192501. PMID: 30468600.
Copy Download .nbib Format: NLM
First Measurement of the g Factor in the Chiral Band: The Case of the ^{128}Cs Isomeric State.

Physical review letters

Grodner E, Srebrny J, Droste C, Próchniak L, Rohoziński SG, Kowalczyk M, Ionescu-Bujor M, Ur CA, Starosta K, Ahn T, Kisieliński M, Marchlewski T, Aydin S, Recchia F, Georgiev G, Lozeva R, Fiori E, Zielińska M, Chen QB, Zhang SQ, Yu LF, Zhao PW, Meng J.
PMID: 29376727
Phys Rev Lett. 2018 Jan 12;120(2):022502. doi: 10.1103/PhysRevLett.120.022502.

The g factor of the 56 ns half-life isomeric state in ^{128}Cs has been measured using the time-differential perturbed angular distribution method. This state is the bandhead of the positive-parity chiral rotational band, which emerges when an unpaired proton,...

Cite
Grodner E, Srebrny J, Droste C, et al. First Measurement of the g Factor in the Chiral Band: The Case of the ^{128}Cs Isomeric State. Phys Rev Lett. 2018;120(2):022502doi: 10.1103/PhysRevLett.120.022502.
Grodner, E., Srebrny, J., Droste, C., Próchniak, L., Rohoziński, S. G., Kowalczyk, M., Ionescu-Bujor, M., Ur, C. A., Starosta, K., Ahn, T., Kisieliński, M., Marchlewski, T., Aydin, S., Recchia, F., Georgiev, G., Lozeva, R., Fiori, E., Zielińska, M., Chen, Q. B., Zhang, S. Q., Yu, L. F., Zhao, P. W., & Meng, J. (2018). First Measurement of the g Factor in the Chiral Band: The Case of the ^{128}Cs Isomeric State. Physical review letters, 120(2), 022502. https://doi.org/10.1103/PhysRevLett.120.022502
Grodner, E, et al. "First Measurement of the g Factor in the Chiral Band: The Case of the ^{128}Cs Isomeric State." Physical review letters vol. 120,2 (2018): 022502. doi: https://doi.org/10.1103/PhysRevLett.120.022502
Grodner E, Srebrny J, Droste C, Próchniak L, Rohoziński SG, Kowalczyk M, Ionescu-Bujor M, Ur CA, Starosta K, Ahn T, Kisieliński M, Marchlewski T, Aydin S, Recchia F, Georgiev G, Lozeva R, Fiori E, Zielińska M, Chen QB, Zhang SQ, Yu LF, Zhao PW, Meng J. First Measurement of the g Factor in the Chiral Band: The Case of the ^{128}Cs Isomeric State. Phys Rev Lett. 2018 Jan 12;120(2):022502. doi: 10.1103/PhysRevLett.120.022502. PMID: 29376727.
Copy Download .nbib Format: NLM
Cross-Linked Imidazolium Salts as Scavengers for Palladium.

ChemPlusChem

Buscemi R, Giacalone F, Orecchio S, Gruttadauria M.
PMID: 31986604
Chempluschem. 2014 Mar;79(3):421-426. doi: 10.1002/cplu.201300361. Epub 2014 Jan 23.

Five imidazolium-based materials have been synthesised and used for the first time as palladium scavengers. Radical reactions of suitable bis-vinylimidazolium salts led to a series of insoluble materials through homo-polymerisation, immobilisation with a 3-mercaptopropyl-modified silica gel or co-polymerisation with...

Cite
Buscemi R, Giacalone F, Orecchio S, et al. Cross-Linked Imidazolium Salts as Scavengers for Palladium. Chempluschem. 2014;79(3):421-426doi: 10.1002/cplu.201300361.
Buscemi, R., Giacalone, F., Orecchio, S., & Gruttadauria, M. (2014). Cross-Linked Imidazolium Salts as Scavengers for Palladium. ChemPlusChem, 79(3), 421-426. https://doi.org/10.1002/cplu.201300361
Buscemi, Roberto, et al. "Cross-Linked Imidazolium Salts as Scavengers for Palladium." ChemPlusChem vol. 79,3 (2014): 421-426. doi: https://doi.org/10.1002/cplu.201300361
Buscemi R, Giacalone F, Orecchio S, Gruttadauria M. Cross-Linked Imidazolium Salts as Scavengers for Palladium. Chempluschem. 2014 Mar;79(3):421-426. doi: 10.1002/cplu.201300361. Epub 2014 Jan 23. PMID: 31986604.
Copy Download .nbib Format: NLM
Correction: Creating genetic reports that are understood by nonspecialists: a case study.

Genetics in medicine : official journal of the American College of Medical Genetics

Recchia G, Chiappi A, Chandratillake G, Raymond L, Freeman ALJ.
PMID: 31548640
Genet Med. 2020 Jan;22(1):240-241. doi: 10.1038/s41436-019-0663-2.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Recchia G, Chiappi A, Chandratillake G, et al. Correction: Creating genetic reports that are understood by nonspecialists: a case study. Genet Med. 2020;22(1):240-241doi: 10.1038/s41436-019-0663-2.
Recchia, G., Chiappi, A., Chandratillake, G., Raymond, L., & Freeman, A. L. J. (2020). Correction: Creating genetic reports that are understood by nonspecialists: a case study. Genetics in medicine : official journal of the American College of Medical Genetics, 22(1), 240-241. https://doi.org/10.1038/s41436-019-0663-2
Recchia, Gabriel, et al. "Correction: Creating genetic reports that are understood by nonspecialists: a case study." Genetics in medicine : official journal of the American College of Medical Genetics vol. 22,1 (2020): 240-241. doi: https://doi.org/10.1038/s41436-019-0663-2
Recchia G, Chiappi A, Chandratillake G, Raymond L, Freeman ALJ. Correction: Creating genetic reports that are understood by nonspecialists: a case study. Genet Med. 2020 Jan;22(1):240-241. doi: 10.1038/s41436-019-0663-2. PMID: 31548640; PMCID: PMC6944642.
Copy Download .nbib Format: NLM
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Oncoimmunology

Riganti C, Lingua MF, Salaroglio IC, Falcomatà C, Righi L, Morena D, Picca F, Oddo D, Kopecka J, Pradotto M, Libener R, Orecchia S, Bironzo P, Comunanza V, Bussolino F, Novello S, Scagliotti GV, Di Nicolantonio F, Taulli R.
PMID: 29399399
Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.

Systemic treatment of malignant pleural mesothelioma (MPM) is moderately active for the intrinsic pharmacological resistance of MPM cell and its ability to induce an immune suppressive environment. Here we showed that the expression of bromodomain (BRD) proteins

Cite
Riganti C, Lingua MF, Salaroglio IC, et al. Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. Oncoimmunology. 2017;7(3):e1398874doi: 10.1080/2162402X.2017.1398874.
Riganti, C., Lingua, M. F., Salaroglio, I. C., Falcomatà, C., Righi, L., Morena, D., Picca, F., Oddo, D., Kopecka, J., Pradotto, M., Libener, R., Orecchia, S., Bironzo, P., Comunanza, V., Bussolino, F., Novello, S., Scagliotti, G. V., Di Nicolantonio, F., & Taulli, R. (2018). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. Oncoimmunology, 7(3), e1398874. https://doi.org/10.1080/2162402X.2017.1398874
Riganti, Chiara, et al. "Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment." Oncoimmunology vol. 7,3 (2018): e1398874. doi: https://doi.org/10.1080/2162402X.2017.1398874
Riganti C, Lingua MF, Salaroglio IC, Falcomatà C, Righi L, Morena D, Picca F, Oddo D, Kopecka J, Pradotto M, Libener R, Orecchia S, Bironzo P, Comunanza V, Bussolino F, Novello S, Scagliotti GV, Di Nicolantonio F, Taulli R. Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018. PMID: 29399399; PMCID: PMC5790353.
Copy Download .nbib Format: NLM
How to Efficiently Produce Ultrapure Acids.

International journal of analytical chemistry

Monticelli D, Castelletti A, Civati D, Recchia S, Dossi C.
PMID: 30713555
Int J Anal Chem. 2019 Jan 01;2019:5180610. doi: 10.1155/2019/5180610. eCollection 2019.

Subboiling distillation has been used since two decades for the purification of analytical grade acids from inorganic contaminants and demonstrated an efficient method to obtain pure acids starting from reagent grade chemicals. Nevertheless, the effect of the subboiling parameters...

Cite
Monticelli D, Castelletti A, Civati D, et al. How to Efficiently Produce Ultrapure Acids. Int J Anal Chem. 2019;2019:5180610doi: 10.1155/2019/5180610.
Monticelli, D., Castelletti, A., Civati, D., Recchia, S., & Dossi, C. (2019). How to Efficiently Produce Ultrapure Acids. International journal of analytical chemistry, 20195180610. https://doi.org/10.1155/2019/5180610
Monticelli, Damiano, et al. "How to Efficiently Produce Ultrapure Acids." International journal of analytical chemistry vol. 2019 (2019): 5180610. doi: https://doi.org/10.1155/2019/5180610
Monticelli D, Castelletti A, Civati D, Recchia S, Dossi C. How to Efficiently Produce Ultrapure Acids. Int J Anal Chem. 2019 Jan 01;2019:5180610. doi: 10.1155/2019/5180610. eCollection 2019. PMID: 30713555; PMCID: PMC6332944.
Copy Download .nbib Format: NLM
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.

European journal of haematology

Gentile M, Shanafelt TD, Mauro FR, Reda G, Rossi D, Laurenti L, Del Principe MI, Cutrona G, Angeletti I, Coscia M, Herishanu Y, Chiarenza A, Molica S, Ciolli S, Goldschmidt N, Angrilli F, Giordano A, Rago A, Bairey O, Tripepi G, Chaffee KG, Sameer PA, Vigna E, Zirlik K, Shvidel L, Innocenti I, Recchia AG, Di Raimondo F, Del Poeta G, Cortelezzi A, Neri A, Ferrarini M, Gaidano G, Kay NE, Polliack A, Foà R, Morabito F.
PMID: 30039576
Eur J Haematol. 2018 Jul 24; doi: 10.1111/ejh.13149. Epub 2018 Jul 24.

No abstract available.

Cite
Gentile M, Shanafelt TD, Mauro FR, et al. Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. Eur J Haematol. 2018;doi: 10.1111/ejh.13149.
Gentile, M., Shanafelt, T. D., Mauro, F. R., Reda, G., Rossi, D., Laurenti, L., Del Principe, M. I., Cutrona, G., Angeletti, I., Coscia, M., Herishanu, Y., Chiarenza, A., Molica, S., Ciolli, S., Goldschmidt, N., Angrilli, F., Giordano, A., Rago, A., Bairey, O., Tripepi, G., Chaffee, K. G., Sameer, P. A., Vigna, E., Zirlik, K., Shvidel, L., Innocenti, I., Recchia, A. G., Di Raimondo, F., Del Poeta, G., Cortelezzi, A., Neri, A., Ferrarini, M., Gaidano, G., Kay, N. E., Polliack, A., Foà, R., & Morabito, F. (2018). Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. European journal of haematology, . https://doi.org/10.1111/ejh.13149
Gentile, Massimo, et al. "Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment." European journal of haematology vol. (2018). doi: https://doi.org/10.1111/ejh.13149
Gentile M, Shanafelt TD, Mauro FR, Reda G, Rossi D, Laurenti L, Del Principe MI, Cutrona G, Angeletti I, Coscia M, Herishanu Y, Chiarenza A, Molica S, Ciolli S, Goldschmidt N, Angrilli F, Giordano A, Rago A, Bairey O, Tripepi G, Chaffee KG, Sameer PA, Vigna E, Zirlik K, Shvidel L, Innocenti I, Recchia AG, Di Raimondo F, Del Poeta G, Cortelezzi A, Neri A, Ferrarini M, Gaidano G, Kay NE, Polliack A, Foà R, Morabito F. Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. Eur J Haematol. 2018 Jul 24; doi: 10.1111/ejh.13149. Epub 2018 Jul 24. PMID: 30039576.
Copy Download .nbib Format: NLM
Neutron Skin Effects in Mirror Energy Differences: The Case of ^{23}Mg-^{23}Na.

Physical review letters

Boso A, Lenzi SM, Recchia F, Bonnard J, Zuker AP, Aydin S, Bentley MA, Cederwall B, Clement E, de France G, Di Nitto A, Dijon A, Doncel M, Ghazi-Moradi F, Gadea A, Gottardo A, Henry T, Hüyük T, Jaworski G, John PR, Juhász K, Kuti I, Melon B, Mengoni D, Michelagnoli C, Modamio V, Napoli DR, Nyakó BM, Nyberg J, Palacz M, Timár J, Valiente-Dobón JJ.
PMID: 30085775
Phys Rev Lett. 2018 Jul 20;121(3):032502. doi: 10.1103/PhysRevLett.121.032502.

Energy differences between analogue states in the T=1/2 ^{23}Mg-^{23}Na mirror nuclei have been measured along the rotational yrast bands. This allows us to search for effects arising from isospin-symmetry-breaking interactions (ISB) and/or shape changes. Data are interpreted in the...

Cite
Boso A, Lenzi SM, Recchia F, et al. Neutron Skin Effects in Mirror Energy Differences: The Case of ^{23}Mg-^{23}Na. Phys Rev Lett. 2018;121(3):032502doi: 10.1103/PhysRevLett.121.032502.
Boso, A., Lenzi, S. M., Recchia, F., Bonnard, J., Zuker, A. P., Aydin, S., Bentley, M. A., Cederwall, B., Clement, E., de France, G., Di Nitto, A., Dijon, A., Doncel, M., Ghazi-Moradi, F., Gadea, A., Gottardo, A., Henry, T., Hüyük, T., Jaworski, G., John, P. R., Juhász, K., Kuti, I., Melon, B., Mengoni, D., Michelagnoli, C., Modamio, V., Napoli, D. R., Nyakó, B. M., Nyberg, J., Palacz, M., Timár, J., & Valiente-Dobón, J. J. (2018). Neutron Skin Effects in Mirror Energy Differences: The Case of ^{23}Mg-^{23}Na. Physical review letters, 121(3), 032502. https://doi.org/10.1103/PhysRevLett.121.032502
Boso, A, et al. "Neutron Skin Effects in Mirror Energy Differences: The Case of ^{23}Mg-^{23}Na." Physical review letters vol. 121,3 (2018): 032502. doi: https://doi.org/10.1103/PhysRevLett.121.032502
Boso A, Lenzi SM, Recchia F, Bonnard J, Zuker AP, Aydin S, Bentley MA, Cederwall B, Clement E, de France G, Di Nitto A, Dijon A, Doncel M, Ghazi-Moradi F, Gadea A, Gottardo A, Henry T, Hüyük T, Jaworski G, John PR, Juhász K, Kuti I, Melon B, Mengoni D, Michelagnoli C, Modamio V, Napoli DR, Nyakó BM, Nyberg J, Palacz M, Timár J, Valiente-Dobón JJ. Neutron Skin Effects in Mirror Energy Differences: The Case of ^{23}Mg-^{23}Na. Phys Rev Lett. 2018 Jul 20;121(3):032502. doi: 10.1103/PhysRevLett.121.032502. PMID: 30085775.
Copy Download .nbib Format: NLM
Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?.

Cancers

Coccaro N, Anelli L, Zagaria A, Perrone T, Specchia G, Albano F.
PMID: 31940809
Cancers (Basel). 2020 Jan 11;12(1). doi: 10.3390/cancers12010185.

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma; it features extreme molecular heterogeneity regardless of the classical cell-of-origin (COO) classification. Despite this, the standard therapeutic approach is still immunochemotherapy (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone-R-CHOP),...

Cite
Coccaro N, Anelli L, Zagaria A, et al. Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?. Cancers (Basel). 2020;12(1)doi: 10.3390/cancers12010185.
Coccaro, N., Anelli, L., Zagaria, A., Perrone, T., Specchia, G., & Albano, F. (2020). Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?. Cancers, 12(1), . https://doi.org/10.3390/cancers12010185
Coccaro, Nicoletta, et al. "Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?." Cancers vol. 12,1 (2020). doi: https://doi.org/10.3390/cancers12010185
Coccaro N, Anelli L, Zagaria A, Perrone T, Specchia G, Albano F. Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?. Cancers (Basel). 2020 Jan 11;12(1). doi: 10.3390/cancers12010185. PMID: 31940809; PMCID: PMC7017344.
Copy Download .nbib Format: NLM
High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.

Journal of contemporary brachytherapy

Vavassori A, Riva G, Spoto R, Lazzari R, Fodor C, Dicuonzo S, Francia CM, Augugliaro M, Facondo G, Cambria R, Comi S, Cattani F, Botta F, Bagnardi V, Rizzo S, Colombo N, Orecchia R, Jereczek-Fossa BA.
PMID: 31969909
J Contemp Brachytherapy. 2019 Dec;11(6):516-526. doi: 10.5114/jcb.2019.90478. Epub 2019 Dec 08.

PURPOSE: To analyse the survival outcomes and toxicity profile of patients treated with pulsed-dose-rate (PDR) brachytherapy (BT) after intensity-modulated radiation therapy (IMRT) for uterine cervical cancer in a single institution.MATERIAL AND METHODS: Between March 2011 and December 2014, 50...

Cite
Vavassori A, Riva G, Spoto R, et al. High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study. J Contemp Brachytherapy. 2019;11(6):516-526doi: 10.5114/jcb.2019.90478.
Vavassori, A., Riva, G., Spoto, R., Lazzari, R., Fodor, C., Dicuonzo, S., Francia, C. M., Augugliaro, M., Facondo, G., Cambria, R., Comi, S., Cattani, F., Botta, F., Bagnardi, V., Rizzo, S., Colombo, N., Orecchia, R., & Jereczek-Fossa, B. A. (2019). High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study. Journal of contemporary brachytherapy, 11(6), 516-526. https://doi.org/10.5114/jcb.2019.90478
Vavassori, Andrea, et al. "High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study." Journal of contemporary brachytherapy vol. 11,6 (2019): 516-526. doi: https://doi.org/10.5114/jcb.2019.90478
Vavassori A, Riva G, Spoto R, Lazzari R, Fodor C, Dicuonzo S, Francia CM, Augugliaro M, Facondo G, Cambria R, Comi S, Cattani F, Botta F, Bagnardi V, Rizzo S, Colombo N, Orecchia R, Jereczek-Fossa BA. High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study. J Contemp Brachytherapy. 2019 Dec;11(6):516-526. doi: 10.5114/jcb.2019.90478. Epub 2019 Dec 08. PMID: 31969909; PMCID: PMC6964350.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 279 entries